Matinas BioPharma Holdings (MTNB) Other Non-Current Assets (2014 - 2026)
Matinas BioPharma Holdings (MTNB) reported Other Non-Current Assets of $200000.0 for Q1 2026, little changed year-over-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $200000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 13 years of Other Non-Current Assets data on file, last reported at $200000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY), and the FY2025 annual result was $200000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $200000.0 in Q1 2026 per MTNB's latest filing, from $200000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $300000.0 in Q2 2022 and troughed at $200000.0 in Q1 2022.
- A 5-year average of $205882.4 and a median of $200000.0 in 2022 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 0.0% in 2022 and fell as far as 33.33% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $200000.0 in 2022, then changed by 0.0% to $200000.0 in 2023, then changed by 0.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows MTNB's Other Non-Current Assets at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |